Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments

Jemaa, S; Paulson, JN; Hutchings, M; Kostakoglu, L; Trotman, J; Tracy, S; de Crespigny, A; Carano, RAD; El-Galaly, TC; Nielsen, TG; Bengtsson, T

Nielsen, TG (通讯作者),F Hoffmann La Roche Ltd, Pharmaceut Dev Clin Oncol, Bldg 1,Grenzarcherstr 124m, CH-4070 Basel, Switzerland.

CANCER IMAGING, 2022; 22 (1):

Abstract

Background: Current radiological assessments of (18)fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging data in diffuse large B-cell lym......

Full Text Link